MDIF 2013 Mobile Healthcare, Medical Device Tax, and the Sunshine Act
Few things are having a more transformative impact on the delivery of healthcare than the mobile technology revolution. Dr. Harry Greenspun is the Senior Advisor for Healthcare Transformation and Technology at the Deloitte Center for Health Solutions (DCHS), part of Deloitte LLP. He has held a diverse range of clinical and executive roles, and is now responsible for helping Deloitte's health care, life sciences, and government clients address key health information technology (IT) and clinical transformation issues.
As the Chairman of the HIMSS Government Relations Roundtable and as co-chair of the HIMSS task force responsible for creating the white paper entitled, "Enabling Healthcare Reform Using Information Technology," Dr. Greenspun has made recommendations to the Obama Administration and U.S. Congress on the importance of health care IT investment to the nation.
Speaker: Harry Greenspun, MD - Senior Advisor, Healthcare Transformation & Technology, Deloitte Center for Health Solutions, Deloitte LLP
The generally accepted response to Affordable Care Act has been to reduce R&D expenditures and, ultimately, the rate of innovation critical to maintain the United States global strategic competitive advantage in life science innovation, and a crucial platform for job creation.
This session discusses the specifics associated with the tax, how it is calculated, and important strategies that life science businesses need in order to deal with the excise tax.
Denise Miley - Managing Director, Tax Services, Grant Thornton
This session discuss the goals and objectives of the Sunshine Act and the resultant implications for the medical device industry, and outlinse strategies that manufacturers can use to ensure their innovation collaborators are not shut off and their product development efforts continue to reflect the true needs of the clinicians.
Todd Theodora - Chief Legal Counsel, Alphaeon